Repaglinide (Prandin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Repaglinide (Prandin), covering 2025-03-17 to 2025-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy Participants [Phase 1]